---
title: "Biophytis Completes €2.6 Million Private Placement"
description: "Biophytis SA has successfully completed a private placement worth approximately €2.6 million, involving the issuance of new ordinary shares and pre-funded warrants now trading on Euronext Growth. This"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/233694251.md"
published_at: "2025-03-28T21:33:49.000Z"
---

# Biophytis Completes €2.6 Million Private Placement

> Biophytis SA has successfully completed a private placement worth approximately €2.6 million, involving the issuance of new ordinary shares and pre-funded warrants now trading on Euronext Growth. This financial move, facilitated by Maxim Group LLC and Invest Securities, aims to strengthen Biophytis's financial position and support its operations in developing treatments for age-related diseases. The company is currently listed on Euronext Growth Paris with a market cap of €3.18 million and has experienced a year-to-date price performance decline of 43.43%.

An update from Biophytis SA ( (FR:ALBPS) ) is now available.

Biophytis SA has completed the settlement and delivery of a private placement valued at approximately 2.6 million euros. This financial maneuver involved the issuance of new ordinary shares and pre-funded warrants, which have been admitted to trading on Euronext Growth. The successful placement, facilitated by Maxim Group LLC and Invest Securities, is expected to enhance Biophytis’s financial position, potentially impacting its operations and market strategy in developing treatments for age-related diseases.

**More about Biophytis SA**

Biophytis SA is a clinical-stage biotechnology company focused on developing treatments for age-related diseases. The company operates in the biotechnology industry and is listed on Euronext Growth Paris.

**YTD Price Performance:** -43.43%

**Average Trading Volume:** 17,907

**Technical Sentiment Signal:** Buy

**Current Market Cap:** €3.18M

For detailed information about ALBPS stock, go to TipRanks’ Stock Analysis page.

## Trending Articles:

-   Paramount Stock (NASDAQ:PARA) Slips as it Loses a Big Name in College Football
-   Manual Transmission Electric Cars? Ford Stock (NYSE:F) Slides on the Notion
-   Intel Stock (NASDAQ:INTC) Plunges as SK hynix Deal Closes

Disclaimer & DisclosureReport an Issue

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Biophytis Releases Interim Financial Report for H1 2025 | Biophytis S.A. released its Interim Financial Report for H1 2025 on October 31, 2025, detailing its financial performanc | [Link](https://longbridge.com/en/news/263767655.md) |
| Maine CDC reports 4 additional cases of measles have been confirmed in Maine | Maine CDC reports 4 additional cases of measles have been confirmed in Maine | [Link](https://longbridge.com/en/news/276164223.md) |
| 08:46 ETCenter for Asbestos Related Disease, Inc. (CARD) Invites Community Members to Attend an Open House and Ribbon Cutting Celebration | The Center for Asbestos Related Disease, Inc. (CARD) is hosting an Open House and Ribbon Cutting celebration on February | [Link](https://longbridge.com/en/news/276235741.md) |
| How Regular Dental Visits Support Oral Health in Vero Beach, FL | Regular dental visits are crucial for maintaining oral health and preventing serious medical issues. They help prevent c | [Link](https://longbridge.com/en/news/276145403.md) |
| 10:39 ETThe EveryLife Foundation for Rare Diseases Marks 15th Annual Rare Disease Week on Capitol Hill | The EveryLife Foundation for Rare Diseases will host its 15th Annual Rare Disease Week on Capitol Hill from February 24- | [Link](https://longbridge.com/en/news/276247135.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.